OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52 | +30.0% | 13,414 | +10.7% | 0.00% | – |
Q2 2023 | $40 | -43.7% | 12,113 | -56.0% | 0.00% | – |
Q1 2023 | $71 | +39.2% | 27,500 | 0.0% | 0.00% | – |
Q4 2022 | $51 | -99.9% | 27,500 | 0.0% | 0.00% | – |
Q3 2022 | $51,000 | -23.9% | 27,500 | -11.7% | 0.00% | – |
Q2 2022 | $67,000 | -43.7% | 31,133 | -18.0% | 0.00% | – |
Q1 2022 | $119,000 | -2.5% | 37,961 | 0.0% | 0.00% | – |
Q4 2021 | $122,000 | -4.7% | 37,961 | 0.0% | 0.00% | – |
Q3 2021 | $128,000 | -13.5% | 37,961 | 0.0% | 0.00% | – |
Q2 2021 | $148,000 | 0.0% | 37,961 | +3.3% | 0.00% | – |
Q1 2021 | $148,000 | -89.7% | 36,748 | -80.1% | 0.00% | – |
Q2 2018 | $1,442,000 | -32.1% | 184,811 | -38.5% | 0.00% | – |
Q1 2018 | $2,124,000 | -28.2% | 300,480 | +0.3% | 0.00% | – |
Q4 2017 | $2,957,000 | -0.5% | 299,570 | -17.2% | 0.00% | -100.0% |
Q3 2017 | $2,971,000 | -18.3% | 361,640 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,637,000 | – | 361,640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |